As per the Official Information Act of 1992, please supply all the clinical safety data, both short term and long term, assessing the safety of administering all the vaccines in the manner and temporal nature of the national immunisation schedule, for every population subset including, but not exclusively, children, adults, elderly, pregnant and breastfeeding women, immunocompromised, etc. Please also supply the clinical safety data across all available populations demonstrating the safety of administering any additional vaccine offered in New Zealand that currently falls outside the National Immunisation Schedule including, but not exclusively, the flu vaccines, chicken pox, shingles vaccines and the new covid vaccine(s) to a person who has previously received every immunisation listed on the national immunisation schedule. Please supply the data you are using to declare to the public that the Pfizer vaccine is safe to administer to a person who has previously received all other vaccines on our National Immunisation Schedule.
Vaccine hesitancy, specifically relating to the new covid vaccine. Confidence in our National Immunisation Schedule, as well as trust in our government currently amending our laws to respond to the covid pandemic.
This data will assist the vaccine hesitant in feeling safe to take the new Covid vaccines. Just simply being told they are safe is not sufficient. The data, which you must currently have open since the leaders of our country are currently declaring them daily, and thus they should be made available to the public to back their claims so that they can feel confident when taking vaccines and give informed consent.
Data does not exist
7 Votes
Agency responded
Ministry of Health COVID-19 Response team (Ministry of Health)
Kia ora Amber
On behalf of the Ministry of Health, thank you for taking the time to contact us. We are currently receiving high volumes of enquiries and are working at pace to ensure we respond to everyone however we do sincerely apologise for the delay in response.
As with any vaccine, the Pfizer vaccine (Comirnaty) may not fully protect everyone who gets it. However, it is highly effective if people have both doses. That means, if you do catch COVID-19, you’re far less likely to fall seriously ill and less likely to transmit the virus to others.
Clinical trials found that the Pfizer vaccine gave 95% protection against the symptoms of COVID-19.
The COVID-19 vaccine stimulates your body’s immune system to produce antibodies and other proteins that will fight the virus if you’re exposed to it. This reduces the risk of getting infected and if you do get COVID-19, it means you could have no symptoms or will have much fewer, milder symptoms and recover faster.
While the data is clear that vaccines protect people from the effects of COVID-19, research is ongoing to determine whether a vaccinated person could still transmit the virus to someone else – so to be safe, we must assume there is still a risk of transmission.
Further information on vaccine effectiveness and protection can be found on the Ministry of Health website: COVID-19: Vaccine effectiveness and protection | Ministry of Health NZ.
You can find specific updates on vaccines and their effect on viral transmission here: science_updates_7_may_2021.pdf (health.govt.nz)
Once again, we apologise for the delay in response and thank you for your patience during these times.
---
Ngā mihi nui
COVID-19 Response and Co-ordination Team
Ministry of Health
Ministry of Health COVID-19 Response team (Ministry of Health)
Kia ora Cassie
On behalf of the Ministry of Health, thank you for taking the time to contact us. We are currently receiving high volumes of enquiries and are working at pace to ensure we respond to everyone however we do sincerely apologise for the delay in response.
COVID-19 vaccines are the most well-studied vaccines ever made. Nearly 50% of the world's population have had a COVID-19 vaccine, and more than 3 million people in Aotearoa have had their first Pfizer vaccine. This means we have lots of data to show the Pfizer vaccine has been thoroughly assessed for safety.
ACC can provide treatment and support for injuries caused by COVID-19 vaccination if the criteria for treatment injury are met. This means there’s a physical injury caused by the vaccination, that’s not a necessary part or ordinary consequence of the treatment.
For example, inflammation around the site of the injection is common with COVID-19 vaccination (an ordinary consequence) and is unlikely to be covered. Infections (such as cellulitis or septic arthritis) due to the vaccination, and anaphylaxis resulting in injury, are not ordinary consequences and are likely to be covered. This is relevant to all vaccinations.
Once again, we apologise for the delay in response and thank you for your patience during these times.
Ngā mihi nui
COVID-19 Response and Co-ordination Team
Ministry of Health
Medsafe (Ministry of Health)
Unfortunately we cannot provide this data as people are not systematically providing us with their medical history when they report an adverse reaction following immunisation. The scientific literature may be a better source of information.
Claire McLauchlan
Please send me the safety data and adverse reactions associated with the following underlying Medical Conditions:
Autoimmune disorders, COPD, Previous history of Thyroid Cancer, Acute Lymphoblastic Leukemia (Childhood), Dementia, Enlarged Heart, Atrial Fibrillation.
Amber
Please tell me how me getting this vaccine "protects others" when transmission was not measured, and I am still able to get and transmit COVID.
Cassie reid
Please send me the details for compensation if I was to have an adverse reaction to the covid jab and what timeframe you base this on, etc.
Especially since all information available is in support of the government. We should have all the facts before making an informed decision.